Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119306 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marguerite S Buzza und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Fibrinolysis, Hemostatics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Hemostasis is a delicate balance between coagulation and fibrinolysis that regulates the formation and removal of fibrin, respectively. Positive and negative feedback loops and crosstalk between coagulation and fibrinolytic serine proteases maintain the hemostatic balance to prevent both excessive bleeding and thrombosis. Here, we identify a novel role for the glycosylphosphatidylinositol (GPI)-anchored serine protease testisin in the regulation of pericellular hemostasis. Using in vitro cell-based fibrin generation assays, we found that the expression of catalytically active testisin on the cell surface accelerates thrombin-dependent fibrin polymerization, and intriguingly, that it subsequently promotes accelerated fibrinolysis. We find that the testisin-dependent fibrin formation is inhibited by rivaroxaban, a specific inhibitor of the central prothrombin-activating serine protease factor Xa (FXa), demonstrating that cell-surface testisin acts upstream of factor X (FX) to promote fibrin formation at the cell surface. Unexpectedly, testisin was also found to accelerate fibrinolysis by stimulating the plasmin-dependent degradation of fibrin and enhancing plasmin-dependent cell invasion through polymerized fibrin. Testisin was not a direct activator of plasminogen, but it is able to induce zymogen cleavage and the activation of pro-urokinase plasminogen activator (pro-uPA), which converts plasminogen to plasmin. These data identify a new proteolytic component that can regulate pericellular hemostatic cascades at the cell surface, which has implications for angiogenesis, cancer biology, and male fertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Research and Development Service, VA Maryland Health Care System, Baltimore, MD 21201, USA.
Förderung
- NHLBI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- BLRD VA
- NCI NIH HHS
- National Institutes of Health (NIH)
- United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Service
- National Cancer Institute Cancer Center Support Grant (CCSG)
Zitieren
APA
Buzza, M. S., Pawar, N. R., Strong, A. A., & Antalis, T. M. (2023). Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119306
Vancouver
Buzza MS, Pawar NR, Strong AA, Antalis TM. Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119306
BibTeX
@article{Buzza2023,
author = {Buzza, Marguerite S and Pawar, Nisha R and Strong, Amando A and Antalis, Toni M},
title = {Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119306}
}
EUVIMED